Search Within

Weinberg Fellows

  1. "Ahmet Dogan"
Formats
  1. Meeting Abstract (50)
  2. Journal Article (23)
  3. Research Letter (3)
  4. Correspondence (1)
Groups
  1. Department of Medicine (77)
  2. Department of Pathology and Laboratory Medicine (77)
  3. Hematologic Malignancies, Division of (77)
  4. Hematology-Oncology Fellows (77)
  5. Center for Hematologic Malignancies (76)
  6. Lymphoma (54)

More Groups

People
  1. Ahmet Dogan (77)
  2. Alison Moskowitz (44)
  3. Anita Kumar (43)
  4. Andrew Zelenetz (41)
  5. Steven Horwitz (40)
  6. Ariela Noy (38)

More People

Years
  1. 2025 (6)
  2. 2024 (14)
  3. 2023 (14)
  4. 2022 (6)
  5. 2021 (14)
  6. 2020 (12)

More Years

Publications
  1. Blood (41)
  2. Blood Advances (4)
  3. Blood Cancer Journal (4)
  4. Hematological Oncology (4)
  5. Journal of Clinical Oncology (4)
  6. Laboratory Investigation (4)

More Publications

Publishers
  1. American Society of Hematology (45)
  2. Nature Publishing Group (8)
  3. American Society of Clinical Oncology (5)
  4. Wiley Blackwell (4)
  5. American Association for Cancer Research (3)
  6. Elsevier Inc. (2)

More Publishers

Results (77)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Treatment outcomes and CNS relapse risk in patients with primary cutaneous DLBCL, leg-type in the rituximab era
    Correspondence

    Cassanello, G.; Drill, E.; Qiu, A.; Ewalt, M. D.; Hamlin, P.; Horwitz, S. M.; Joffe, E.; Kumar, A.; Moskowitz, A. J.; Noy, A.; more...
    Blood Cancer Journal (2025)

    Fulltext@MSK | Save
  • Correlation between TP53 mutational status and digital quantification of p53 immunohistochemistry in mantle cell lymphoma
    Journal Article

    Yan, M.; Sethi, S.; Epstein-Peterson, Z.; Kumar, A.; Dogan, A.; Galera, P.
    Virchows Archiv (2025)

    Fulltext@MSK | Save
  • Defining 2 biologically and clinically distinct groups in acute leukemia with a mixed phenotype
    Journal Article

    Galera, P.; Dilip, D.; Derkach, A.; Chan, A.; Zhang, Y.; Persaud, S.; Mishra, T.; Kramer, K.; Kathpalia, M.; Liu, Y.; more...
    Blood (2025)

    Fulltext@MSK | Save
  • A patient-derived T cell lymphoma biorepository uncovers pathogenetic mechanisms and host-related therapeutic vulnerabilities
    Journal Article

    Fiore, D.; Cappelli, L. V.; Zhaoqi, L.; Kotlov, N.; Sorokina, M.; Phillip, J.; Zumbo, P.; Yoffe, L.; Ghione, P.; Wang, A.; more...
    Cell Reports Medicine (2025)

    Fulltext@MSK | Save
  • Phase II trial of nivolumab plus doxorubicin, vinblastine, dacarbazine as frontline therapy in older adults with Hodgkin lymphoma
    Journal Article

    Torka, P.; Feldman, T.; Savage, K. J.; Ganesan, N.; Drill, E.; Hancock, H.; Davey, T.; Perez, L.; Capadona, C.; Subzwari, S.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Phase I trial of MCARH109, a G protein-coupled receptor class C group 5 member D (GPRC5D)-targeted chimeric antigen receptor T-cell therapy for multiple myeloma: An updated analysis
    Journal Article

    Jurgens, E. M.; Firestone, R. S.; Chaudhari, J.; Hosszu, K.; Devlin, S. M.; Shah, U. A.; Landa, J.; McAvoy, D. P.; Lesokhin, A. M.; Korde, N.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • CD5 expression in marginal zone lymphoma does not predict inferior outcome and has similarities to indolent lymphomas
    Journal Article

    Ghione, P.; Bantilan, K. S.; Joffe, E.; Palomba, M. L.; Noy, A.; Caron, P.; Hamlin, P.; Kumar, A.; Matasar, M.; Owens, C.; more...
    Blood Neoplasia (2024)

    Fulltext@MSK | Save
  • Sequential R-CHOP/(R)-ICE and dose-adjusted EPOCH-R are both appropriate frontline treatments for newly diagnosed primary mediastinal B-cell lymphoma: Results of a retrospective analysis
    Meeting Abstract

    Bantilan, K. S.; Luttwak, E.; Moskowitz, C. H.; Matasar, M.; Straus, D. J.; Portlock, C. S.; Moskowitz, A.; Noy, A.; Palomba, M. L.; Horwitz, S.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Angioimmunoblastic versus non-angioimmunoblastic nodal T-follicular helper cell lymphomas: Single center retrospective analysis on 208 cases
    Meeting Abstract

    Sordi, B.; Eren, O. C.; Ganesan, N.; Iyengar, V.; Stuver, R.; Johnson, W. T.; Moskowitz, A.; Ghione, P.; Galasso, N.; Casper, E.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Pembrolizumab and involved site radiation therapy alone as an alternative to transplant in patients with localized failure following chemotherapy for Hodgkin Lymphoma: A prospective multicenter phase II study
    Meeting Abstract

    Dreyfuss, A.; Ganesan, N.; Alencar, A. J.; Boardman, A. P.; Caron, P.; Chang, T.; Davey, T.; David, K. A.; Dogan, A.; Epstein-Peterson, Z. D.; more...
    Blood (2024)

    Fulltext@MSK | Save